MetLife Investment Management’s Tivity Health, Inc. Common Stock TVTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-26,102
Closed -$840K 2937
2022
Q1
$840K Buy
26,102
+8,908
+52% +$241K 0.01% 1446
2021
Q4
$455K Hold
17,194
﹤0.01% 1557
2021
Q3
$396K Hold
17,194
﹤0.01% 1659
2021
Q2
$452K Hold
17,194
﹤0.01% 1627
2021
Q1
$384K Sell
17,194
-4,944
-22% -$113K ﹤0.01% 1674
2020
Q4
$434K Hold
22,138
﹤0.01% 1563
2020
Q3
$310K Hold
22,138
﹤0.01% 1614
2020
Q2
$251K Buy
+22,138
New +$202K ﹤0.01% 1766
2020
Q1
Sell
-21,321
Closed -$434K 2324
2019
Q4
$434K Hold
21,321
﹤0.01% 1542
2019
Q3
$355K Hold
21,321
﹤0.01% 1602
2019
Q2
$351K Hold
21,321
﹤0.01% 1702
2019
Q1
$374K Buy
21,321
+2,641
+14% +$56.2K ﹤0.01% 1625
2018
Q4
$463K Hold
18,680
0.01% 1416
2018
Q3
$601K Hold
18,680
0.01% 1417
2018
Q2
$658K Buy
18,680
+2,441
+15% +$90.1K 0.01% 1245
2018
Q1
$644K Hold
16,239
0.01% 1224
2017
Q4
$594K Buy
+16,239
New +$616K 0.01% 1312

Other funds holding TVTY

MetLife Investment Management's TVTY Position: Q2 2022 in Review

MetLife Investment Management sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 26,102 shares — an estimated $840K sold.

MetLife Investment Management first reported a position in TVTY in Q4 2017 and held it in 17 quarters. The position peaked at $840K in Q1 2022. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.

  • MetLife Investment Management reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • MetLife Investment Management sold 26,102 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $840K.
  • MetLife Investment Management first reported a position in Tivity Health, Inc. Common Stock in Q4 2017 and held it in 17 quarters.
  • MetLife Investment Management's Tivity Health, Inc. Common Stock position peaked at $840K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.

Based on MetLife Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.